Grumet M, Milev P, Sakurai T, Karthikeyan L, Bourdon M, Margolis R K, Margolis R U
Department of Pharmacology, New York University Medical Center, New York 10016.
J Biol Chem. 1994 Apr 22;269(16):12142-6.
We have studied interactions of tenascin with two chondroitin sulfate proteoglycans, neurocan and phosphacan. Neurocan is a multi-domain proteoglycan with a 136-kDa core protein that is synthesized by neurons and binds to hyaluronic acid, whereas the 173-kDa core protein of phosphacan, which is synthesized by glia, represents an extracellular variant of the receptor-type protein tyrosine phosphatase RPTP zeta/beta. Keratan sulfate-containing glycoforms of phosphacan (designated phosphacan-KS) are also present in brain. Immunocytochemical studies of early postnatal rat cerebellum demonstrated that the localization of neurocan, phosphacan, and phosphacan-KS all overlap extensively with that of tenascin, an extracellular matrix protein that modulates cell adhesion and migration. Binding studies using purified proteins covalently attached to fluorescent microbeads demonstrated that proteoglycan-coated beads co-aggregated with differently fluorescing beads coated with tenascin. The co-aggregation was specifically inhibited by Fab' fragments of antibodies against tenascin or the proteoglycans and by soluble neurocan, phosphacan, and tenascin. A solid phase radioligand binding assay confirmed that neurocan, phosphacan, and phosphacan-KS bind to tenascin but not to laminin and fibronectin. Chondroitinase treatment of the proteoglycans or addition of free chondroitin sulfate had no significant effect, indicating that the binding activity is mediated largely via the core glycoproteins. Scatchard analysis demonstrated high affinity binding of 125I-phosphacan, phosphacan-KS, and neurocan to a single site in tenascin, and neurocan and various glycoforms of phosphacan all inhibited binding of 125I-phosphacan to tenascin. In studies of cell adhesion to proteins adsorbed to Petri dishes, phosphacan inhibited adhesion of C6 glioma cells to tenascin whereas neurocan had no effect. Our results suggest that tenascin binds phosphacan and neurocan in vivo and that interactions between chondroitin sulfate proteoglycans and tenascin may play important roles in nervous tissue histogenesis, possibly by modulating signal transduction across the plasma membrane.
我们研究了腱生蛋白与两种硫酸软骨素蛋白聚糖——神经聚糖和磷蛋白聚糖的相互作用。神经聚糖是一种多结构域蛋白聚糖,其核心蛋白为136 kDa,由神经元合成并与透明质酸结合,而磷蛋白聚糖的173 kDa核心蛋白由神经胶质细胞合成,是受体型蛋白酪氨酸磷酸酶RPTP ζ/β的细胞外变体。含硫酸角质素的磷蛋白聚糖糖型(称为磷蛋白聚糖-KS)也存在于大脑中。对出生后早期大鼠小脑的免疫细胞化学研究表明,神经聚糖、磷蛋白聚糖和磷蛋白聚糖-KS的定位都与腱生蛋白(一种调节细胞黏附和迁移的细胞外基质蛋白)的定位广泛重叠。使用共价连接到荧光微珠上的纯化蛋白进行的结合研究表明,蛋白聚糖包被的珠子与不同荧光的腱生蛋白包被的珠子共聚集。这种共聚集被抗腱生蛋白或蛋白聚糖的抗体的Fab'片段以及可溶性神经聚糖、磷蛋白聚糖和腱生蛋白特异性抑制。固相放射性配体结合试验证实,神经聚糖、磷蛋白聚糖和磷蛋白聚糖-KS与腱生蛋白结合,但不与层粘连蛋白和纤连蛋白结合。对蛋白聚糖进行软骨素酶处理或添加游离硫酸软骨素没有显著影响,表明结合活性主要通过核心糖蛋白介导。Scatchard分析表明,125I-磷蛋白聚糖、磷蛋白聚糖-KS和神经聚糖与腱生蛋白中的单个位点具有高亲和力结合,并且神经聚糖和磷蛋白聚糖的各种糖型均抑制125I-磷蛋白聚糖与腱生蛋白的结合。在对吸附到培养皿上的蛋白质的细胞黏附研究中,磷蛋白聚糖抑制C6胶质瘤细胞与腱生蛋白的黏附,而神经聚糖没有作用。我们的结果表明,腱生蛋白在体内与磷蛋白聚糖和神经聚糖结合,硫酸软骨素蛋白聚糖与腱生蛋白之间的相互作用可能在神经组织组织发生中起重要作用,可能是通过调节跨质膜的信号转导来实现的。